Trial Profile
A Phase I, Single Center, Open Label, Single-Dose, Five-Period Study to Compare the Pharmacokinetics of NP101 (Sumatriptan Iontophoretic Transdermal Patch) in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Apr 2012
Price :
$35
*
At a glance
- Drugs Sumatriptan (Primary)
- Indications Migraine
- Focus Pharmacokinetics
- Sponsors NuPathe
- 11 Dec 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Dec 2008 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
- 12 Aug 2008 New trial record.